Universe Pharmaceuticals INC (UPC)
NASDAQ: UPC · Real-Time Price · USD
3.600
-0.800 (-18.18%)
Aug 14, 2025, 11:53 AM - Market open
UPC Income Statement
Financials in millions USD. Fiscal year is October - September.
Millions USD. Fiscal year is Oct - Sep.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 | Sep '20 Sep 30, 2020 | 2019 - 2020 |
| 19.29 | 23.02 | 32.31 | 40.14 | 47.98 | 30.7 | Upgrade | |
Revenue Growth (YoY) | -27.81% | -28.74% | -19.52% | -16.34% | 56.27% | -7.60% | Upgrade |
Cost of Revenue | 13.43 | 16.95 | 21.99 | 18.25 | 22.66 | 16.61 | Upgrade |
Gross Profit | 5.87 | 6.07 | 10.32 | 21.89 | 25.33 | 14.09 | Upgrade |
Selling, General & Admin | 11.43 | 11.06 | 9.33 | 21.27 | 6.17 | 3.16 | Upgrade |
Research & Development | 3.04 | 3.03 | 4.86 | 7.64 | 5.47 | 0.58 | Upgrade |
Other Operating Expenses | 0 | 0 | 0.1 | - | 0.1 | 0.1 | Upgrade |
Operating Expenses | 14.47 | 14.09 | 14.28 | 28.91 | 11.74 | 3.84 | Upgrade |
Operating Income | -8.61 | -8.02 | -3.97 | -7.02 | 13.59 | 10.25 | Upgrade |
Interest Expense | -0.3 | -0.3 | -0.19 | -0.2 | -0.15 | -0.16 | Upgrade |
Interest & Investment Income | 0.03 | 0.03 | 0.03 | 0.04 | 0.29 | 0.03 | Upgrade |
Earnings From Equity Investments | 0.03 | 0.03 | 0.03 | 0.04 | 0.03 | 0.02 | Upgrade |
Other Non Operating Income (Expenses) | -0.83 | 0.15 | -0.24 | 0.05 | -0.08 | -0.05 | Upgrade |
EBT Excluding Unusual Items | -9.68 | -8.12 | -4.33 | -7.09 | 13.68 | 10.1 | Upgrade |
Gain (Loss) on Sale of Assets | -0 | -0 | -0 | -0 | -0 | - | Upgrade |
Pretax Income | -9.68 | -8.12 | -4.33 | -7.09 | 13.68 | 10.1 | Upgrade |
Income Tax Expense | -0.06 | 0.61 | 2.25 | 0.82 | 2.36 | 2.54 | Upgrade |
Net Income | -9.62 | -8.73 | -6.58 | -7.91 | 11.32 | 7.56 | Upgrade |
Net Income to Common | -9.62 | -8.73 | -6.58 | -7.91 | 11.32 | 7.56 | Upgrade |
Net Income Growth | - | - | - | - | 49.77% | 0.09% | Upgrade |
Shares Outstanding (Basic) | 0 | 0 | - | - | - | - | Upgrade |
Shares Outstanding (Diluted) | 0 | 0 | - | - | - | - | Upgrade |
EPS (Basic) | -52.07 | -626.96 | - | - | - | - | Upgrade |
EPS (Diluted) | -52.07 | -626.96 | - | - | - | - | Upgrade |
Free Cash Flow | -4.79 | -9.75 | 1.07 | -1.4 | -15.59 | 6.06 | Upgrade |
Free Cash Flow Per Share | -25.92 | -700.61 | - | - | - | - | Upgrade |
Gross Margin | 30.41% | 26.37% | 31.93% | 54.53% | 52.78% | 45.90% | Upgrade |
Operating Margin | -44.61% | -34.83% | -12.28% | -17.49% | 28.32% | 33.39% | Upgrade |
Profit Margin | -49.87% | -37.90% | -20.37% | -19.70% | 23.59% | 24.62% | Upgrade |
Free Cash Flow Margin | -24.83% | -42.36% | 3.32% | -3.48% | -32.48% | 19.75% | Upgrade |
EBITDA | -8.1 | -7.53 | -3.46 | -6.49 | 14.04 | 10.66 | Upgrade |
EBITDA Margin | -41.98% | -32.72% | -10.70% | -16.16% | 29.25% | 34.73% | Upgrade |
D&A For EBITDA | 0.51 | 0.49 | 0.51 | 0.53 | 0.45 | 0.41 | Upgrade |
EBIT | -8.61 | -8.02 | -3.97 | -7.02 | 13.59 | 10.25 | Upgrade |
EBIT Margin | -44.61% | -34.83% | -12.28% | -17.49% | 28.32% | 33.39% | Upgrade |
Effective Tax Rate | - | - | - | - | 17.24% | 25.17% | Upgrade |
Advertising Expenses | - | 5.27 | 4.76 | - | 1.33 | 0.36 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.